WAM
PRAH

Wealthspire Advisors (Maryland)’s PRA Health Sciences, Inc. PRAH Stock Holding History

Wealthspire Advisors (Maryland)’s Portfolio PRAH Stock Details PRAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-69
Closed -$8K – 2342
2019
Q1 		$8K Sell
69
-39
-36% -$4.08K ﹤0.01% 1649
2018
Q4 		$10K Sell
108
-265
-71% -$26.8K ﹤0.01% 1485
2018
Q3 		$41K Sell
373
-221
-37% -$23K ﹤0.01% 1042
2018
Q2 		$55K Sell
594
-98
-14% -$8.44K 0.01% 943
2018
Q1 		$57K Hold
692
– – 0.01% 933
2017
Q4 		$63K Sell
692
-21
-3% -$1.75K 0.01% 917
2017
Q3 		$54K Buy
713
+136
+24% +$10.3K 0.01% 951
2017
Q2 		$43K Hold
577
– – 0.01% 1003
2017
Q1 		$38K Sell
577
-224
-28% -$13.2K 0.01% 880
2016
Q4 		$44K Buy
801
+126
+19% +$6.92K 0.01% 810
2016
Q3 		$38K Buy
675
+13
+2% +$637 0.01% 864
2016
Q2 		$28K Buy
662
+264
+66% +$12.2K ﹤0.01% 891
2016
Q1 		$17K Sell
398
-189
-32% -$7.99K ﹤0.01% 1027
2015
Q4 		$27K Buy
+587
New +$24.7K 0.01% 889

Other funds holding PRAH

KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Wealthspire Advisors (Maryland)'s PRAH Position: Q2 2019 in Review

Wealthspire Advisors (Maryland) sold out of PRA Health Sciences, Inc. (PRAH) in Q2 2019, closing a stake of 69 shares — an estimated $8K sold.

Wealthspire Advisors (Maryland) first reported a position in PRAH in Q4 2015 and held it in 14 quarters. The position peaked at $63K in Q4 2017. 329 funds tracked by Wall St. Rank hold PRAH as of Q2 2019.

  • Wealthspire Advisors (Maryland) reported no remaining PRA Health Sciences, Inc. position as of Q2 2019 after selling out during the quarter.
  • Wealthspire Advisors (Maryland) sold 69 PRA Health Sciences, Inc. shares in Q2 2019, an estimated $8K.
  • Wealthspire Advisors (Maryland) first reported a position in PRA Health Sciences, Inc. in Q4 2015 and held it in 14 quarters.
  • Wealthspire Advisors (Maryland)'s PRA Health Sciences, Inc. position peaked at $63K in Q4 2017.
  • 329 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q2 2019.

Based on Wealthspire Advisors (Maryland)'s 13F filing for Q2 2019, filed 12 Aug 2019.